ADTX News and Press, ADiTx Therapeutics Inc. From 12/28/21

If complete, the transaction would be the first step in establishing commercial presence in infectious disease therapeutics and transforming Aditxt into a global biotech company Aditxt Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the ...

3 Penny Stocks For Your Watchlist As the Bull Run Continues With penny stocks and blue chips seeing another bull run today, investors are excited about what the future could hold. Despite fears surrounding the Omicron variant, the Dow managed to jump to near-record highs, up 225 points ...

Aditxt (NASDAQ:ADTX) to acquire a company focused on developing Point-of-Care diagnostics for early detection of diseases including cancers and SARS-CoV-2 through a range of non-invasive and affordable point of care and at-home/in-office test kits. The target holds an exclusive license in ...

The target holds an exclusive license in U.S. & Canada for at-home and in-office rapid antigen COVID-19 test EUA application for the COVID-19 rapid antigen test was submitted in September 2021 Target acquisition has a range of rapid Point-of-Care diagnostics within their por...

Aditxt, Inc. (“Aditxt”, or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the closing of its previously announced underwritten public offering of 16,575,000 units, consist...

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today that it has entered into an amendment to its previously announced transaction agreement with A...

Gainers: Arbutus Biopharma (NASDAQ:ABUS) +87%. MDJM (NASDAQ:MDJH) +41%. Context Therapeutics (NASDAQ:CNTX) +35%. Build-A-Bear Workshop (NYSE:BBW) +33%. Ardelyx (NASDAQ:ARDX) +28%. Ambarella (NASDAQ:AMBA) +25%. Roivant Sciences (NASDAQ:ROIV) +22%. Stran & Company (NASDAQ:STRN) +20%. Marpai...

Gainers: Arbutus Biopharma (NASDAQ:ABUS) +47%. Ardelyx (NASDAQ:ARDX) +31%. Context Therapeutics (NASDAQ:CNTX) +19%. ImmunoGen (NASDAQ:IMGN) +17%. Skylight Health Group (NASDAQ:SLHG) +16%. Losers: BeyondSpring (NASDAQ:BYSI) -53%. Aditxt (NASDAQ:ADTX) -25%. CTI (NASDAQ:CTIC)...

Aditxt (ADTX -25.6%) prices an underwritten public offering of ~16.58M units for $1.05 per unit; gross proceeds of ~$17.4M. Underwriter's granted a 45-day option to purchase up to ~2.49M additional shares of common stock and/or warrants. Offering is expected to close on December 3, ...

Aditxt, Inc. (“Aditxt”, or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today the pricing of an underwritten public offering of 16,575,000 units, consisting of shares of its c...